The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi)

M. Makarova (Moscow, Russian Federation)

Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Session: Clinical challenges in chronic lung diseases
Session type: Thematic Poster
Number: 714
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Makarova (Moscow, Russian Federation). The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi). 714

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012


Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections
Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016
Year: 2017


Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Source: Eur Respir J 2009; 34: 926-931
Year: 2009



Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS)
Source: Eur Respir J 2001; 18: Suppl. 33, 308s
Year: 2001

Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Characterization of drug susceptibility of nontuberculous mycobacteria of M.chelonae and M.fortuitum complexes.
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018

Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013



Characteristics of drug susceptibility of M. abscessus subsp. abscessus and M.chelonae
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011


Invasive Mycobacterium avium intracellulare infection
Source: Eur Respir J 2006; 28: Suppl. 50, 312s
Year: 2006

Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008



Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001

On the nature of Mycobacterium tuberculosis-latent bacilli
Source: Eur Respir J 2004; 24: 1044-1051
Year: 2004



Long-term survival of patients with mycobacterium avium- intracellulare complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections
Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017
Year: 2017



Identification of nontuberculous mycobacteria using GenoType® Mycobacterium CM
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010


Mycobacterium xenopi pulmonary disease in Croatia
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017